Claude Nicaise - Mar 16, 2023 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role
Director
Signature
/s/ Matthew Rudolph, Esq., Attorney-in-Fact for Claude Nicaise
Stock symbol
CMMB
Transactions as of
Mar 16, 2023
Transactions value $
$0
Form type
4
Date filed
3/23/2023, 07:36 AM
Previous filing
Mar 8, 2023
Next filing
Jun 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMMB Option to Purchase American Depositary Shares Award $0 +6.86K $0.00 6.86K Mar 16, 2023 American Depositary Shares 6.86K $1.62 Direct F1, F2
transaction CMMB Option to Purchase American Depositary Shares Award $0 +6.82K $0.00 6.82K Mar 16, 2023 American Depositary Shares 6.82K $3.53 Direct F2, F3, F4
transaction CMMB Option to Purchase American Depositary Shares Award $0 +11.9K $0.00 11.9K Mar 16, 2023 American Depositary Shares 11.9K $27.26 Direct F2, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted as per the annual grant of options to directors. These options vest and become exercisable in their entirety on March 16, 2024, subject to the Reporting Person's continued service.
F2 Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F3 No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F4 These options vested and became exercisable in their entirety on March 16, 2023. These options were granted as per the annual grant of options to directors.
F5 These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.